{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:05:48Z","timestamp":1794485148456,"version":"4.9.1"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.brainresbull.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T14:32:57Z","timestamp":1540477977000},"page":"155-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":702,"special_numbering":"C","title":["Evaluation of intranasal delivery route of drug administration for brain targeting"],"prefix":"10.1016","volume":"143","author":[{"given":"Franciska","family":"Erd\u0151","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Anna","family":"Bors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Bajza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-9752","authenticated-orcid":false,"given":"Sveinbj\u00f6rn","family":"Gizurarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2018.10.009_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.eplepsyres.2013.02.018","article-title":"A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers","volume":"105","author":"Agarwal","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2003.12.005","article-title":"Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze","volume":"361","author":"Alcalay","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jps.21031","article-title":"Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies","volume":"97","author":"Bai","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0025","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awn193","article-title":"Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (hypocretin-1)","volume":"131","author":"Baier","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2174\/1381612043384862","article-title":"Are the extracelluar pathways a conduit for the delivery of therapeutics to the brain?","volume":"10","author":"Banks","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0196-9781(99)00139-4","article-title":"Impaired transport of leptin across the blood-brain barrier in obesity","volume":"20","author":"Banks","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.102.036129","article-title":"Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse","volume":"302","author":"Banks","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.58.1.0008","article-title":"Carbamazepine uptake into rat brain following intra-olfactory transport","volume":"58","author":"Barakat","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0050","series-title":"The Blood-Brain Barrier","author":"Bates","year":"2014"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(97)00064-1","article-title":"Optimization of systemic nasal drug delivery with pharmaceutical excipients","volume":"29","author":"Behl","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2337\/db10-0329","article-title":"Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men","volume":"60","author":"Benedict","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0065","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0070","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/jc.2007-2606","article-title":"Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin","volume":"93","author":"Benedict","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study","volume":"321","author":"Bistritzer","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0095","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","article-title":"SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat","volume":"82","author":"Burright","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0100","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1073\/pnas.192442999","article-title":"Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice","volume":"99","author":"Capsoni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.brainresbull.2011.11.004","article-title":"Intranasally applied l-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions","volume":"87","author":"Chao","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0110","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejps.2006.11.018","article-title":"Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device","volume":"30","author":"Charlton","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Chaturvedi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","article-title":"Delivery of nerve growth factor to the brain via the olfactory pathway","volume":"1","author":"Chen","year":"1998","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0130","first-page":"1322","article-title":"Advantageous nasal drug delivery system: a review","volume":"2","author":"Chhajed","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4333\/KPS.2010.40.6.321","article-title":"In vitro nasal cell culture systems for drug transport studies","volume":"40","author":"Cho","year":"2010","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0145","series-title":"Handbook of Olfaction and Gustation","article-title":"Anatomy of the human nasal passages","author":"Clerico","year":"2003"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01133","article-title":"A novel approach to reinstating tolerance in experimental autoimmune myasthenia gravis using a targeted fusion protein, mCTA1-T146","volume":"8","author":"Consonni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0160","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/ar.20592","article-title":"Reconstruction and morphometric analysis of the nasal airway of the dog (Canis familiaris) and implications regarding olfactory airflo","volume":"290","author":"Craven","year":"2007","journal-title":"Anat. Rec."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3317\/jraas.2001.019","article-title":"The renin\u2013angiotensin system in the brain: an update","volume":"2","author":"Culman","year":"2001","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0928-0987(01)00151-8","article-title":"Levels of dopamine in blood and brain following nasal administration to rats","volume":"14","author":"Dahlin","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0180","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1021\/mp400735c","article-title":"Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles","volume":"11","author":"Dalpiaz","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","article-title":"A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations","volume":"51","author":"De Haan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0190","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1073\/pnas.0500195102","article-title":"Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice","volume":"102","author":"De Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0195","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","author":"Deli","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0205","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.113.02860","article-title":"Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked","volume":"63","author":"Derad","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0895-7061(98)00095-8","article-title":"Intranasal angiotensin II directly influences central nervous regulation of blood pressure","volume":"11","author":"Derad","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0215","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0220","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1073\/pnas.0403172101","article-title":"Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I","volume":"101","author":"Digicaylioglu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"25","author":"Djupesland","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijpharm.2016.05.010","article-title":"Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells","volume":"508","author":"Dolberg","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0240","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","article-title":"Oxytocin improves \u201cMind-Reading\u201d in humans","volume":"61","author":"Domes","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","article-title":"Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects","volume":"9","author":"Drejer","year":"1992","journal-title":"Diabet. Med."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","article-title":"Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats","volume":"255","author":"Dufes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0255","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0265","first-page":"64","article-title":"Olfactory transfer of analgesic drugs after nasal administration","volume":"55","author":"Espef\u00e4lt Westin","year":"2007","journal-title":"Digit. Compr. Summ. Uppsala Diss. from Fac. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(00)00540-9","article-title":"Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?","author":"Fehm","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0280","first-page":"1144","article-title":"The melanocortin melanocyte-stimulating hormone\/adrenocorticotropin(4\u201310) decreases body fat in humans","volume":"86","author":"Fehm","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0285","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/088307380201700206","article-title":"Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study","volume":"17","author":"Fi\u015fgin","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT 1 receptor in brain endothelial cells","volume":"29","author":"Fleegal-Demotta","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0295","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1210\/en.2005-1016","article-title":"Brain uptake of intranasally applied radioiodinated leptin in Wistar rats","volume":"147","author":"Fliedner","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2007.05.026","article-title":"Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration","volume":"121","author":"Gao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.12.046","article-title":"Nanoparticle transport across in vitro olfactory cell monolayers","volume":"499","author":"Gartziandia","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0310","series-title":"Particle Dispersion Device for Nasal Delivery","author":"Giroux","year":"2007"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0315","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/156720112803529828","article-title":"Anatomical and histological factors affecting intranasal drug and vaccine delivery","volume":"9","author":"Gizurarson","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0320","first-page":"105","article-title":"Animal models for intranasal drug delivery studies. A review article","volume":"2","author":"Gizurarson","year":"1990","journal-title":"Acta Pharm. Nord."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1248\/bpb.22.425","article-title":"Intranasal administration of diazepam aiming at the treatment of acute seizures: clinical trials in healthy volunteers","volume":"22","author":"Gizurarson","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10517-010-1058-1","article-title":"Antiamnestic effects of antibodies to glutamate in experimental alzheimer\u2019s disease","volume":"150","author":"Gorbatov","year":"2010","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0340","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1073\/pnas.82.21.7419","article-title":"Nasal absorption of insulin: enhancement by hydrophobic bile salts","volume":"82","author":"Gordon","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0345","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.peptides.2010.10.030","article-title":"Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate","volume":"32","author":"Gozes","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0350","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-3565(24)39336-X","article-title":"Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze","volume":"293","author":"Gozes","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11095-004-9013-3","article-title":"Functional evidence for P-glycoprotein at the nose-brain barrier","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1389200043489126","article-title":"Drug transport at the blood-brain barrier and the choroid plexus","volume":"5","author":"Graff","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0365","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1023\/A:1025053115583","article-title":"P-glycoprotein attenuates brain uptake of substrates after nasal instillation","volume":"20","author":"Graff","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0370","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11095-004-1191-5","article-title":"Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0375","series-title":"Gray\u2019s Anatomy","author":"Gray","year":"1978"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0380","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J. Anat."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0385","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"18","key":"10.1016\/j.brainresbull.2018.10.009_bib0390","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005344-199108000-00006","article-title":"Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability","volume":"1","author":"Guillot","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0395","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejps.2017.02.032","article-title":"Nose-to-brain transport of imatinib mesylate: a pharmacokinetic evaluation","volume":"102","author":"Hada","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0400","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1210\/jc.2005-0906","article-title":"Brief report: overweight humans are resistant to the weight-reducing effects of melanocortin4-10","volume":"91","author":"Hallschmid","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0405","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-S3-S5","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0410","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1215\/15228517-2007-052","article-title":"New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163","volume":"10","author":"Hashizume","year":"2008","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0420","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","article-title":"Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress","volume":"54","author":"Heinrichs","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0425","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.eplepsyres.2014.04.007","article-title":"Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults","volume":"108","author":"Henney","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0430","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(02)00077-7","article-title":"Characterization of human nasal primary culture systems to investigate peptide metabolism","volume":"238","author":"Hoang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0435","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archpediatrics.2010.130","article-title":"Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy","volume":"164","author":"Holsti","year":"2010","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0440","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/bpb.17.316","article-title":"Evaluation of enhancers to increase nasal absorption using Ussing chamber technique","volume":"17","author":"Hosoya","year":"1994","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0445","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12031-013-9993-8","article-title":"Saturable leptin transport across the BBB persists in EAE mice","volume":"51","author":"Hsuchou","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0450","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery--possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0460","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eplepsyres.2012.07.018","article-title":"Bioavailability of Intranasal vs. Rectal Diazepam","volume":"103","author":"Ivaturi","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0465","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/156720106777731118","article-title":"Applications of microemulsion based drug delivery system","volume":"3","author":"Jadhav","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0470","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WAD.0b013e318157205b","article-title":"Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting","volume":"22","author":"Jogani","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0475","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yebeh.2015.04.027","article-title":"Intranasal therapies for acute seizures","volume":"49","author":"K\u00e4lvi\u00e4inen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0480","doi-asserted-by":"crossref","DOI":"10.3390\/ph11010009","article-title":"Improved intranasal retentivity and transnasal absorption enhancement by PEGylated poly-L-ornithine","volume":"11","author":"Kamiya","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0485","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2005.06.012","article-title":"Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules","volume":"302","author":"Kandimalla","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0490","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.22070","article-title":"Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders","volume":"68","author":"Kang","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0495","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02975453","article-title":"Brain uptake and the analgesic effect of oxytocin--its usefulness as an analgesic agent","volume":"23","author":"Kang","year":"2000","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0500","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10717540802006377","article-title":"Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers","volume":"15","author":"Karasulu","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0505","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","article-title":"Central nervous system effects of intranasally administered insulin during euglycemia in men","volume":"48","author":"Kern","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0510","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0515","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1211\/jpp.61.05.0017","article-title":"Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats","volume":"61","author":"Khan","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0520","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0525","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0530","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0535","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00027","article-title":"Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types","volume":"9","author":"Kou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0540","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10717544.2017.1377316","article-title":"Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy","volume":"24","author":"Kou","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0545","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/en.2002-220982","article-title":"A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse","volume":"144","author":"Krasnow","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0550","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","article-title":"Nasal delivery systems and their effect on deposition and absorption","volume":"29","author":"Kublik","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0555","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2013.03.012","article-title":"In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration","volume":"50","author":"K\u00fcrti","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0560","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/npp.2010.123","article-title":"Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder","volume":"35","author":"Labuschagne","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0565","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ymthe.2005.12.013","article-title":"Intranasal administration of the growth-compromised HSV-2 vector \u0394RR prevents kainate-induced seizures and neuronal loss in rats and mice","volume":"13","author":"Laing","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brainresbull.2017.07.006","article-title":"Intranasal nerve growth factor attenuating the seizure onset via p75R\/Caspase pathway in the experimental epilepsy","volume":"134","author":"Lei","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0575","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.1998.tb10551.x","article-title":"Compensatory responses to early olfactory restriction","author":"Leon","year":"1998","journal-title":"Ann. New York Acad. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0580","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2004.05.026","article-title":"Transepithelial electrical measurements with the Ussing chamber","volume":"3","author":"Li","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0585","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/bmj.282.6259.212","article-title":"Clinical pharmacology: plasma protein binding of drugs","volume":"282","author":"Lindup","year":"1981","journal-title":"Br. Med. J."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0590","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0595","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0600","doi-asserted-by":"crossref","first-page":"14127","DOI":"10.3390\/ijms131114127","article-title":"Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice","volume":"13","author":"Lu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0605","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.xphs.2015.12.016","article-title":"Development and evaluation of a novel intranasal spray for the delivery of amantadine","volume":"105","author":"Lungare","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0610","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-9-117","article-title":"Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone","volume":"9","author":"Ma","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2008.04.003","article-title":"Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia","volume":"437","author":"Ma","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0620","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yebeh.2004.01.003","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children","volume":"5","author":"Mahmoudian","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0625","first-page":"1562","article-title":"Design, Development and evaluation studies of buccal adhesive diltiazem tablets using natural edible mucoadhesives","volume":"6","author":"Mangilal","year":"2014","journal-title":"Int. J. Pharmtech Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0630","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1517\/17425247.2014.894504","article-title":"Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC\/mass spectrometry method","volume":"11","author":"Md","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0635","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0640","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.vaa.2017.06.003","article-title":"Intranasal fentanyl for acute severe pain episodes control in a dog","volume":"44","author":"Micieli","year":"2017","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0645","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/acs.molpharmaceut.5b00088","article-title":"Nose-to-Brain delivery: investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium","volume":"12","author":"Mistry","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0650","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0655","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/BF02758299","article-title":"Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures","volume":"73","author":"Mittal","year":"2006","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0660","doi-asserted-by":"crossref","DOI":"10.1254\/jphs.93.437","article-title":"Acquired nasal hyperresponsiveness aggravates antigen-induced rhinitis in the guinea pig","volume":"93","author":"Mizutani","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0665","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/03639045.2010.539231","article-title":"In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain","volume":"37","author":"Montenegro","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0670","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1749-6632.1998.tb10595.x","article-title":"The human vomeronasal system: a review","author":"Monti-Bloch","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0675","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0300985816629712","article-title":"Comparison of two US sheep scrapie isolates supports identification as separate strains","volume":"53","author":"Moore","year":"2016","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0680","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02991098","article-title":"Anatomy and physiology of the nose-pathophysiologic alterations in allergic rhinitis","volume":"2","author":"Mygind","year":"1984","journal-title":"Clin. Rev. Allergy"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0685","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(97)00058-6","article-title":"Anatomy, physiology and function of the nasal cavities in health and disease","volume":"29","author":"Mygind","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0690","first-page":"295","article-title":"Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits","volume":"11","author":"Najafabadi","year":"2004","journal-title":"Drug Deliv. J. Deliv. Target. Ther. Agents"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0695","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-5173(95)04416-7","article-title":"In vitro and in vivo nasal mucoadhesion of some water-soluble polymers","volume":"134","author":"Nakamura","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0700","unstructured":"Nasal Cavity [WWW Document], 2017. Respir. Syst. URL http:\/\/www.therespiratorysystem.com\/nasal-cavity\/."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0705","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2017.0148","article-title":"Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage","author":"Nijboer","year":"2018","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0710","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0715","article-title":"Access to the olfactory region","volume":"27","author":"Olafsson","year":"2000","journal-title":"Proc. Control. Release Bioact. Mater."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/309342","article-title":"Clinical pharmacology of midazolam in neonates and children: effect of disease\u2014a review","volume":"2014","author":"Pacifici","year":"2014","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0725","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0730","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10717544.2012.752421","article-title":"Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach","volume":"20","author":"Pardeshi","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0735","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0740","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/1061186X.2010.523787","article-title":"Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route","volume":"19","author":"Patel","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0745","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0378-5173(88)90277-3","article-title":"The influence of solution viscosity on nasal spray deposition and clearance","volume":"43","author":"Pennington","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0750","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","article-title":"Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier","volume":"91","author":"Polt","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0755","series-title":"The Nose: Upper Airway Physiology and the Atmospheric Enviroment","author":"Proctor","year":"1982"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0760","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.lfs.2018.06.032","article-title":"Intranasal delivery of a novel acetylcholinesterase inhibitor HLS-3 for treatment of Alzheimer\u2019s disease","volume":"207","author":"Qian","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0765","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2010.04.014","article-title":"Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope","volume":"225","author":"Rakover","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0770","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer\u2019s disease-like pathology in amyloid precursor protein-transgenic mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0775","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0780","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10517-010-0929-9","article-title":"Effect of antibodies to glutamate on retention of conditioned passive avoidance response in rats with ischemic injury of the prefrontal cortex","volume":"149","author":"Romanova","year":"2010","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0785","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon \u03b2 bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0790","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1124\/jpet.116.235192","article-title":"Intranasal opioid administration in Rhesus monkeys: PET imaging and antinociception","volume":"359","author":"Saccone","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0795","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0800","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2210-7-7","article-title":"Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa","volume":"7","author":"Sato","year":"2007","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0805","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12035-011-8229-6","article-title":"Brain insulin signaling and Alzheimer\u2019s disease: current evidence and future directions","volume":"46","author":"Schi\u00f6th","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0810","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-409X(97)00061-6","article-title":"In vitro cell models to study nasal mucosal permeability and metabolism","volume":"29","author":"Schmidt","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0815","series-title":"Nasal Tumors in Animals and Man","article-title":"Nasal airway anatomy and inhalation deposition in experimental animals and people","author":"Schreider","year":"1983"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0820","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0825","series-title":"Nasal Delivery Device","author":"Shahaf","year":"2016"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0830","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/156010","article-title":"Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation","volume":"2014","author":"Sharma","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0835","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.peptides.2011.03.016","article-title":"Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) ameliorates hypobaric hypoxia induced oxidative stress in rat brain","volume":"32","author":"Sharma","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0840","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2009.02.011","article-title":"NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model","volume":"34","author":"Shiryaev","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0845","first-page":"208","article-title":"Nano formulation: a novel approach for nose to brain drug delivery","volume":"8","author":"Singh","year":"2016","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0850","first-page":"213","article-title":"Preliminary pharmaceutical characterization of some flowers as natural indicator","volume":"5","author":"Singh","year":"2011","journal-title":"Pharma Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0855","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004714-200008000-00009","article-title":"Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone","volume":"20","author":"Smolnik","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0860","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0865","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s11095-009-9907-1","article-title":"A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs","volume":"26","author":"Stevens","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0870","first-page":"113","article-title":"Newer drug delivery systems","volume":"6","author":"Streisand","year":"1995","journal-title":"Curr. Anaesth. Crit. Care"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0875","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2741\/e209","article-title":"Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats","volume":"2","author":"Sun","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197101","article-title":"A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies","volume":"13","author":"Tan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0885","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00415-012-6659-3","article-title":"A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures","volume":"260","author":"Thakker","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-012-0111-1","article-title":"Nasal drug delivery","volume":"3","author":"Touitou","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0895","first-page":"419","article-title":"Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage","volume":"68","author":"Van Velthoven","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0900","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.brainresbull.2006.02.020","article-title":"Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice","volume":"69","author":"Vig","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0905","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00280-005-0018-3","article-title":"Study on brain targeting of raltitrexed following intranasal administration in rats","volume":"57","author":"Wang","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00341-7","article-title":"Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats","volume":"263","author":"Wang","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2006.02.055","article-title":"Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method","volume":"317","author":"Wang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0920","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2008.09.030","article-title":"Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia","volume":"446","author":"Wang","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0925","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jddst.2016.05.003","article-title":"Formulation and device design to increase nose to brain drug delivery","volume":"35","author":"Warnken","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0930","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1398-9995.1999.tb04402.x","article-title":"Applied anatomy and physiology of the nose and paranasal sinuses","volume":"54","author":"Watelet","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0935","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2009.08.008","article-title":"RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies","volume":"74","author":"Wengst","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0940","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1213\/01.ane.0000226150.90317.16","article-title":"Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers","volume":"103","author":"Wermeling","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0945","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1016210231121","article-title":"Development of a human nasal epithelial cell culture model and its suitability for transport and metabolism studies under in vitro conditions","volume":"12","author":"Werner","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0950","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2005.01.009","article-title":"Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents","volume":"24","author":"Westin","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0955","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00418-008-0410-2","article-title":"Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat","volume":"130","author":"Wolburg","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0960","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0965","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.06.060","article-title":"The doseeffectiveness of intranasal VEGF in treatment of experimental stroke","volume":"461","author":"Xu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0970","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI33009","article-title":"Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents","volume":"118","author":"Xu","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0975","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2008.10.090","article-title":"Direct transport of VEGF from the nasal cavity to brain","volume":"449","author":"Yang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2018.10.009_bib0980","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/10717544.2011.557785","article-title":"Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia","volume":"18","author":"Zhu","year":"2011","journal-title":"Drug Deliv."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018303678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018303678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:32:45Z","timestamp":1759782765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923018303678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":196,"alternative-id":["S0361923018303678"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.009","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of intranasal delivery route of drug administration for brain targeting","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}